EnlargeCNBC reader comments 73 Share this story With rage surging over claims of price gouging, EpiPen manufacturer Mylan took a page from Turing’s playbook today. CEO Heather Bresch told CNBC that the company is taking “immediate action” to make the life-saving auto-injectors available to any patients that need one. The company will expand discounts...